Maravai LifeSciences Holdings, Inc. (MRVI) stock
MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.40−0.14 (-1.86%)
Close on Nov 16, 2026Market cap $1.92BP/E –Yield –
Maravai LifeSciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Maravai LifeSciences's enterprise value was $1.35B on Nov 11, 2026, against $755.30M a year earlier. Over the last 5 years it ranged from $504.02M to $10.28B, with a median of $1.38B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.35B | +92.6% |
| 2025 | Dec 31, 2025 | $702.19M | -26.1% |
| 2024 | Dec 31, 2024 | $949.67M | -31.4% |
| 2023 | Dec 29, 2023 | $1.38B | -60.1% |
| 2022 | Dec 30, 2022 | $3.47B | -60.7% |
| 2021 | Jan 29, 2021 | $8.82B | +24.3% |
| 2020 | Dec 31, 2020 | $7.10B | – |
See a number that looks wrong?